Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 6/2011

01-06-2011 | Original Article

The importance of appropriate partial volume correction for PET quantification in Alzheimer’s disease

Authors: Benjamin A. Thomas, Kjell Erlandsson, Marc Modat, Lennart Thurfjell, Rik Vandenberghe, Sebastien Ourselin, Brian F. Hutton

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 6/2011

Login to get access

Abstract

Purpose

Alzheimer’s disease (AD) is the most common form of dementia. Clinically, it is characterized by progressive cognitive and functional impairment with structural hallmarks of cortical atrophy and ventricular expansion. Amyloid plaque aggregation is also known to occur in AD subjects. In-vivo imaging of amyloid plaques is now possible with positron emission tomography (PET) radioligands. PET imaging suffers from a degrading phenomenon known as the partial volume effect (PVE). The quantitative accuracy of PET images is reduced by PVEs primarily due to the limited spatial resolution of the scanner. The degree of PVE is influenced by structure size, with smaller structures tending to suffer from more severe PVEs such as atrophied grey matter regions. The aims of this paper were to investigate the effect of partial volume correction (PVC) on the quantification of amyloid PET and to highlight the importance of selecting an appropriate PVC technique.

Methods

An improved PVC technique, region-based voxel-wise (RBV) correction, was compared against existing Van-Cittert (VC) and Müller-Gärtner (MG) methods using amyloid PET imaging data. Digital phantom data were produced using segmented MRI scans from a control subject and an AD subject. Typical tracer distributions were generated for each of the phantom anatomies. Also examined were 70 clinical PET scans acquired using [18F]flutemetamol. Volume of interest (VOI) analysis was performed for corrected and uncorrected images.

Results

PVC was shown to improve the quantitative accuracy of regional analysis performed on amyloid PET images. Of the corrections applied, VC deconvolution demonstrated the worst recovery of grey matter values. MG PVC was shown to induce biases in some grey matter regions due to grey matter variability. In addition, white matter variability was shown to influence the accuracy of MG PVC in cortical grey matter and also cerebellar grey matter, a typical reference region for amyloid PET normalization in sporadic AD. RBV was shown to be more accurate than MG in terms of grey matter and white matter uptake. An increase in within-group variability after PVC was observed and is believed to be a genuine, more accurate representation of the data rather than a correction-induced error. The standardized uptake value ratio (SUVR) threshold for classifying subjects as either amyloid-positive or amyloid-negative was found to be 1.64 in the uncorrected dataset, rising to 2.25 after PVC.

Conclusion

Care should be taken when applying PVC to amyloid PET images. Assumptions made in existing PVC strategies can induce biases that could lead to erroneous inferences about uptake in certain regions. The proposed RBV PVC technique accounts for within-compartment variability, with the potential to reduce errors of this kind.
Literature
1.
go back to reference Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, et al. The public health impact of Alzheimer’s disease, 2000–2050: potential implication of treatment advances. Annu Rev Public Health. 2002;23:213–31.PubMedCrossRef Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, et al. The public health impact of Alzheimer’s disease, 2000–2050: potential implication of treatment advances. Annu Rev Public Health. 2002;23:213–31.PubMedCrossRef
2.
go back to reference Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306–19.PubMedCrossRef Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306–19.PubMedCrossRef
3.
go back to reference Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, et al. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (Flobetapir F 18). J Nucl Med. 2010;51:913–20.PubMedCrossRef Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, et al. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (Flobetapir F 18). J Nucl Med. 2010;51:913–20.PubMedCrossRef
4.
go back to reference Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O’Keefe G, et al. Imaging of amyloid β in Alzheimer’s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol. 2008;7:129–35.PubMedCrossRef Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O’Keefe G, et al. Imaging of amyloid β in Alzheimer’s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol. 2008;7:129–35.PubMedCrossRef
5.
go back to reference Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, et al. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol. 2010;68:319–29PubMedCrossRef Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, et al. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol. 2010;68:319–29PubMedCrossRef
6.
go back to reference Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932–45.PubMedCrossRef Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932–45.PubMedCrossRef
7.
go back to reference Frisoni G, Laakso M, Beltramello A, Geroldi C, Bianchetti A, Soininen H, et al. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease. Neurology. 1999;52:91–100.PubMed Frisoni G, Laakso M, Beltramello A, Geroldi C, Bianchetti A, Soininen H, et al. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease. Neurology. 1999;52:91–100.PubMed
8.
go back to reference Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, et al. Dynamics of gray matter loss in Alzheimer’s disease. J Neurosci. 2003;23:994–1005.PubMed Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, et al. Dynamics of gray matter loss in Alzheimer’s disease. J Neurosci. 2003;23:994–1005.PubMed
9.
go back to reference Jack CR, Shiung MM, Weigand SD, O’Brien PC, Gunter JL, Boeve BF, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology. 2005;65:1227–31.PubMedCrossRef Jack CR, Shiung MM, Weigand SD, O’Brien PC, Gunter JL, Boeve BF, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology. 2005;65:1227–31.PubMedCrossRef
10.
go back to reference Tohka J, Reilhac A. Deconvolution-based partial volume correction in Raclopride-PET and Monte Carlo comparison to MR-based method. Neuroimage. 2008;39:1570–84.PubMedCrossRef Tohka J, Reilhac A. Deconvolution-based partial volume correction in Raclopride-PET and Monte Carlo comparison to MR-based method. Neuroimage. 2008;39:1570–84.PubMedCrossRef
11.
go back to reference Mawlawi O, Podoloff DA, Kohlmyer S, Williams JJ, Stearns CW, Culp RF, et al. Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes. J Nucl Med. 2004;45:1734–42.PubMed Mawlawi O, Podoloff DA, Kohlmyer S, Williams JJ, Stearns CW, Culp RF, et al. Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes. J Nucl Med. 2004;45:1734–42.PubMed
12.
go back to reference Teo BK, Seo Y, Bacharach SL, Carrasquillo JA, Libutti SK, Shukla H, et al. Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. J Nucl Med. 2007;48:802–10.PubMed Teo BK, Seo Y, Bacharach SL, Carrasquillo JA, Libutti SK, Shukla H, et al. Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. J Nucl Med. 2007;48:802–10.PubMed
13.
go back to reference Aston JA, Cunningham VJ, Asselin MC, Hammers A, Evans AC, Gunn RN. Positron emission tomography partial volume correction: estimation and algorithms. J Cereb Blood Flow Metab. 2002;22:1019–34.PubMedCrossRef Aston JA, Cunningham VJ, Asselin MC, Hammers A, Evans AC, Gunn RN. Positron emission tomography partial volume correction: estimation and algorithms. J Cereb Blood Flow Metab. 2002;22:1019–34.PubMedCrossRef
14.
go back to reference Meltzer CC, Leal JP, Mayberg HS, Wagner HNJ, Frost JJ. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J Comput Assist Tomogr. 1990;14:561–70.PubMedCrossRef Meltzer CC, Leal JP, Mayberg HS, Wagner HNJ, Frost JJ. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J Comput Assist Tomogr. 1990;14:561–70.PubMedCrossRef
15.
go back to reference Müller-Gärtner HW, Links JM, Prince JL, Bryan RN, McVeigh E, Leal JP, et al. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab. 1992;12:571–83.PubMedCrossRef Müller-Gärtner HW, Links JM, Prince JL, Bryan RN, McVeigh E, Leal JP, et al. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab. 1992;12:571–83.PubMedCrossRef
16.
go back to reference Rousset OG, Ma Y, Evans AC. Correction for partial volume effects in PET: principle and validation. J Nucl Med. 1998;39:904–11.PubMed Rousset OG, Ma Y, Evans AC. Correction for partial volume effects in PET: principle and validation. J Nucl Med. 1998;39:904–11.PubMed
17.
go back to reference Lucy L. An iterative technique for the rectification of observed distributions. Astron J. 1974;79:745–54.CrossRef Lucy L. An iterative technique for the rectification of observed distributions. Astron J. 1974;79:745–54.CrossRef
18.
go back to reference Tohka J, Reilhac A. A Monte Carlo study of deconvolution algorithms for partial volume correction in quantitative PET. Nuclear Science Symposium Conference Record, 2006. IEEE, vol 6, p. 3339–3345. doi:10.1109/NSSMIC.2006.353719 Tohka J, Reilhac A. A Monte Carlo study of deconvolution algorithms for partial volume correction in quantitative PET. Nuclear Science Symposium Conference Record, 2006. IEEE, vol 6, p. 3339–3345. doi:10.​1109/​NSSMIC.​2006.​353719
19.
go back to reference Boussion N, Hatt M, Lamare F, Bizais Y, Turzo A, Rest C, et al. A multiresolution image based approach for correction of partial volume effects in emission tomography. Phys Med Biol. 2006;51:1857–76.PubMedCrossRef Boussion N, Hatt M, Lamare F, Bizais Y, Turzo A, Rest C, et al. A multiresolution image based approach for correction of partial volume effects in emission tomography. Phys Med Biol. 2006;51:1857–76.PubMedCrossRef
20.
go back to reference Le Pogam A, Boussion N, Hatt M, Turkheimer F, Prunier-Aesch C, Guilloteau D, et al. A 3D multi resolution local analysis approach for correction of partial volume effects in emission tomography. Nuclear Science Symposium Conference Record, 2008. NSS' 08, IEEE, p. 5300–5303. doi:10.1109/NSSMIC.2008.4774429 Le Pogam A, Boussion N, Hatt M, Turkheimer F, Prunier-Aesch C, Guilloteau D, et al. A 3D multi resolution local analysis approach for correction of partial volume effects in emission tomography. Nuclear Science Symposium Conference Record, 2008. NSS' 08, IEEE, p. 5300–5303. doi:10.​1109/​NSSMIC.​2008.​4774429
21.
go back to reference Shidahara M, Tsoumpas C, Hammers A, Boussion N, Visvikis D, Suhara T, et al. Functional and structural synergy for resolution recovery and partial volume correction in brain PET. Neuroimage. 2009;44:340–8.PubMedCrossRef Shidahara M, Tsoumpas C, Hammers A, Boussion N, Visvikis D, Suhara T, et al. Functional and structural synergy for resolution recovery and partial volume correction in brain PET. Neuroimage. 2009;44:340–8.PubMedCrossRef
22.
go back to reference Alessio AM, Kinahan PE. Improved quantitation for PET/CT image reconstruction with system modeling and anatomical priors. Med Phys. 2006;33:4095–103.PubMedCrossRef Alessio AM, Kinahan PE. Improved quantitation for PET/CT image reconstruction with system modeling and anatomical priors. Med Phys. 2006;33:4095–103.PubMedCrossRef
23.
go back to reference Rizzo G, Castiglioni I, Russo G, Tana MG, Dell’Acqua F, Gilardi MC, et al. Using deconvolution to improve PET spatial resolution in OSEM iterative reconstruction. Method Inform Med. 2007;46:231–5. Rizzo G, Castiglioni I, Russo G, Tana MG, Dell’Acqua F, Gilardi MC, et al. Using deconvolution to improve PET spatial resolution in OSEM iterative reconstruction. Method Inform Med. 2007;46:231–5.
24.
go back to reference Kirov AS, Piao JZ, Schmidtlein CR. Partial volume effect correction in PET using regularized iterative deconvolution with variance control based on local topology. Phys Med Biol. 2008;53:2577–91.PubMedCrossRef Kirov AS, Piao JZ, Schmidtlein CR. Partial volume effect correction in PET using regularized iterative deconvolution with variance control based on local topology. Phys Med Biol. 2008;53:2577–91.PubMedCrossRef
25.
go back to reference Rousset OG, Ma Y, Wong DF, Evans AC. Pixel- versus region-based partial volume correction in PET. In: Carson RE, Daube-Witherspoon ME, Herscovitch P, editors. Quantitative functional brain imaging with positron emission tomography. San Diego: Academic Press; 1998. p. 67–75.CrossRef Rousset OG, Ma Y, Wong DF, Evans AC. Pixel- versus region-based partial volume correction in PET. In: Carson RE, Daube-Witherspoon ME, Herscovitch P, editors. Quantitative functional brain imaging with positron emission tomography. San Diego: Academic Press; 1998. p. 67–75.CrossRef
26.
go back to reference Quarantelli M, Berkouk K, Prinster A, Landeau B, Svarer C, Balkay L, et al. Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med. 2004;45:192–201.PubMed Quarantelli M, Berkouk K, Prinster A, Landeau B, Svarer C, Balkay L, et al. Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med. 2004;45:192–201.PubMed
27.
go back to reference Yang J, Huang S, Mega M, Lin K, Toga A, Small G, et al. Investigation of partial volume correction methods for brain FDG PET studies. IEEE Trans Nucl Sci. 1996;43:3322–7.CrossRef Yang J, Huang S, Mega M, Lin K, Toga A, Small G, et al. Investigation of partial volume correction methods for brain FDG PET studies. IEEE Trans Nucl Sci. 1996;43:3322–7.CrossRef
28.
go back to reference Erlandsson K, Wong AT, van Heertum R, Mann JJ, Parsey RV. An improved method for voxel-based partial volume correction in PET and SPECT. Neuroimage. 2006;31:T84.CrossRef Erlandsson K, Wong AT, van Heertum R, Mann JJ, Parsey RV. An improved method for voxel-based partial volume correction in PET and SPECT. Neuroimage. 2006;31:T84.CrossRef
29.
go back to reference Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341–55.PubMedCrossRef Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341–55.PubMedCrossRef
30.
go back to reference Fischl B, van der Kouwe A, Destrieux C, Halgren E, Ségonne F, Salat DH, et al. Automatically parcellating the human cerebral cortex. Cereb Cortex. 2004;14:11–22.PubMedCrossRef Fischl B, van der Kouwe A, Destrieux C, Halgren E, Ségonne F, Salat DH, et al. Automatically parcellating the human cerebral cortex. Cereb Cortex. 2004;14:11–22.PubMedCrossRef
31.
go back to reference Braak H, Braak E. Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging. 1995;16:271–8.PubMedCrossRef Braak H, Braak E. Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging. 1995;16:271–8.PubMedCrossRef
32.
go back to reference Ourselin S, Roche A, Subsol G, Pennec X, Ayache N. Reconstructing a 3D structure from serial histological sections. Image Vision Comput. 2001;19:25–31.CrossRef Ourselin S, Roche A, Subsol G, Pennec X, Ayache N. Reconstructing a 3D structure from serial histological sections. Image Vision Comput. 2001;19:25–31.CrossRef
33.
go back to reference Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, et al. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2008;35:2169–81.PubMedCrossRef Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, et al. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2008;35:2169–81.PubMedCrossRef
34.
go back to reference Boussion N, Cheze Le Rest C, Hatt M, Visvikis D. Incorporation of wavelet-based denoising in iterative deconvolution for partial volume correction in whole-body PET imaging. Eur J Nucl Med Mol Imaging. 2009;36:1064–75.PubMedCrossRef Boussion N, Cheze Le Rest C, Hatt M, Visvikis D. Incorporation of wavelet-based denoising in iterative deconvolution for partial volume correction in whole-body PET imaging. Eur J Nucl Med Mol Imaging. 2009;36:1064–75.PubMedCrossRef
35.
go back to reference Ercoli LM, Siddarth P, Kepe V, Miller KJ, Huang SC, Cole GM, et al. Differential FDDNP PET patterns in nondemented middle-aged and older adults. Am J Geriatr Psychiatry. 2009;17:397–406.PubMedCrossRef Ercoli LM, Siddarth P, Kepe V, Miller KJ, Huang SC, Cole GM, et al. Differential FDDNP PET patterns in nondemented middle-aged and older adults. Am J Geriatr Psychiatry. 2009;17:397–406.PubMedCrossRef
36.
go back to reference Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB. Voxel-based analysis of Alzheimer’s disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG. Neuroimage. 2010;52:488–96.PubMedCrossRef Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB. Voxel-based analysis of Alzheimer’s disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG. Neuroimage. 2010;52:488–96.PubMedCrossRef
37.
go back to reference Frouin V, Comtat C, Reilhac A, Gregoire MC. Correction of partial-volume effect for PET striatal imaging: fast implementation and study of robustness. J Nucl Med. 2002;43:1715–26.PubMed Frouin V, Comtat C, Reilhac A, Gregoire MC. Correction of partial-volume effect for PET striatal imaging: fast implementation and study of robustness. J Nucl Med. 2002;43:1715–26.PubMed
Metadata
Title
The importance of appropriate partial volume correction for PET quantification in Alzheimer’s disease
Authors
Benjamin A. Thomas
Kjell Erlandsson
Marc Modat
Lennart Thurfjell
Rik Vandenberghe
Sebastien Ourselin
Brian F. Hutton
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 6/2011
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-011-1745-9

Other articles of this Issue 6/2011

European Journal of Nuclear Medicine and Molecular Imaging 6/2011 Go to the issue